GIC backs Chinese drugmaker Hua Medicine's $117.4m Series D & E round

GIC backs Chinese drugmaker Hua Medicine's $117.4m Series D & E round

Photographer: Krisztian Bocsi/Bloomberg

28 March, 2018

6 Dimensions Capital ally bridge group ARCH Venture Partners AVICT Global Holdings Blue Pool Capital Limited Eight Roads F-Prime Capital Partners GIC Private Limited Harvest Investments Hua Medicine K11 Investments Mirae Asset Financial Group Ping An Ventures Venrock WuXi AppTec Corporate Ventures

Printed by Unregistered user on Tue, 16 Dec 2025 22:21:36 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Chinese AI chip firm Biren eyes Hong Kong IPO in coming weeks

Policy & Regulations

Beijing bourse weighs overhaul of IPO subscription rules as idle capital surges